Almoosa Health Company (TADAWUL:4018)
118.80
-0.40 (-0.34%)
Jul 2, 2026, 3:17 PM AST
Almoosa Health Company Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Almoosa Health Company stock has a consensus rating of "Hold" and an average price target of SAR 165.13. The average 1-year stock price forecast is 39.00% higher than the current stock price, while the lowest is SAR 135.00 (+13.64%) and the highest is SAR 191.50 (+61.20%).
Price Target: SAR 165.13 (+39.00%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Almoosa Health Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
1.64B
from 1.42B
Increased by 16.04%
Revenue Next Year
2.10B
from 1.64B
Increased by 27.94%
EPS This Year
5.93
from 5.52
Increased by 7.34%
EPS Next Year
5.68
from 5.93
Decreased by -4.22%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | ||
| Avg | 1.6B | ||
| Low | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.6% | ||
| Avg | 16.0% | ||
| Low | 10.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.93 | ||
| Avg | 5.93 | ||
| Low | 5.93 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.3% | ||
| Avg | 7.3% | ||
| Low | 7.3% |